Prognostic outcomes of surgical modalities and predictive factors for distant metastases in T1a renal cell carcinoma: a SEER database analysis

T1a期肾细胞癌手术方式的预后结果及远处转移的预测因素:基于SEER数据库的分析

阅读:1

Abstract

BACKGROUND: Distant metastases can still occur in T1a renal cancer. There is no conclusive evidence to determine whether cytoreductive partial nephrectomy (cPN) or cytoreductive radical nephrectomy (cRN) is superior in managing primary renal lesions. This study aimed to compare survival outcomes between cPN and cRN in pathological T1a renal cell carcinoma (RCC) patients with distant metastases and to develop a predictive model for metastasis risk stratification. METHODS: T1a RCC patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Prognostic comparisons were made using Kaplan-Meier analysis. Univariate and multivariate logistic regression analyses were conducted to assess the risk factors for distant metastases in T1a RCC, leading to the development of a predictive model. The model's performance was evaluated using receiver operating characteristic (ROC) curves. RESULTS: The study included 55,957 RCC patients with pathologic T1a, of which 1,496 (2.67%) with distant metastases. Metastatic patients exhibited significantly worse overall survival (OS) than non-metastatic counterparts (P<0.001). There was no notable difference in OS between cPN and cRN (P=0.11). Univariate and multivariate analyses identified advanced age, male gender, poor histological differentiation, sarcomatoid features, capsular invasion, and lymph node metastasis as independent risk factors for distant metastases in RCC patients with stage T1a. The predictive model established on these factors demonstrated performance with an area under the curve of 0.789. CONCLUSIONS: There was no significant difference in OS between cPN and cRN. Advanced age, male gender, poor histological differentiation, capsular invasion, sarcomatoid features, and lymph node metastasis were independent risk factors for distant metastases in RCC patients with stage T1a.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。